Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DROXIDOPA vs NOREPINEPHRINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DROXIDOPA vs NOREPINEPHRINE: Safety Overview

Metric DROXIDOPA NOREPINEPHRINE
Total FAERS Reports 20,119 5,103
Deaths Reported 2,500 1,673
Death Rate 12.4% 32.8%
Hospitalizations 2,900 2,668
Average Patient Age 67.7 yrs 57.9 yrs
% Female Patients 46.7% 33.9%
FDA Approval Date Apr 28, 2021 Approved Prior to Jan 1, 1982
Manufacturer Aurobindo Pharma Limited Civica, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription